Articles in Press
Volume 5 Issue 1
Sequential Nonarteritic Anterior Ischemic Optic Neuropathy after Vardenafil Assumption
Arturo Carta1*,Fernando Onofrio Avellis2, Stefano Gandolfi3
Vardenafil (Levitra, Bayer Pharmaceuticals, Leverkusen,Germany) is one of the phosphodiesterase type 5 inhibitors (PDE-5i) approved for the treatment of erectile dysfunction. Several case reports (other than small case series) have described a possible causative effect between PDE-5i inhibitors assumption and Non-Arteritic Ischemic Optic Neuropathy (NAION) since 2006.